Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials

Seema Pursnani, Frederick Korley, Ravindra Gopaul, Pushkar Kanade, Newry Chandra, Richard E. Shaw, Sripal Bangalore

Research output: Contribution to journalArticle

Abstract

Background: The role of percutaneous coronary intervention (PCI) in the management of stable coronary artery disease remains controversial. Given advancements in medical therapies and stent technology over the last decade, we sought to evaluate whether PCI, when added to medical therapy, improves outcomes when compared with medical therapy alone. Methods and Results: We performed a systematic review and meta-analysis, searching PubMed, EMBASE, and CENTRAL databases, until January 2012, for randomized clinical trials comparing revascularization with PCI to optimal medical therapy (OMT) in patients with stable coronary artery disease. The primary outcome was all-cause mortality, and secondary outcomes included cardiovascular death, nonfatal myocardial infarction, subsequent revascularization, and freedom from angina. Primary analyses were based on longest available follow-up with secondary analyses stratified by trial duration, with short-term (≤1 year), intermediate (1-5 years), and long-term (≥5 years) time points. We identified 12 randomized clinical trials enrolling 7182 participants who fulfilled our inclusion criteria. For the primary analyses, when compared with OMT, PCI was associated with no significant improvement in mortality (risk ratio [RR], 0.85; 95% CI, 0.71-1.01), cardiac death (RR, 0.71; 95% CI, 0.47-1.06), nonfatal myocardial infarction (RR, 0.93; 95% CI, 0.70-1.24), or repeat revascularization (RR, 0.93; 95% CI, 0.76-1.14), with consistent results over all follow-up time points. Sensitivity analysis restricted to studies in which there was >50% stent use showed attenuation in the effect size for all-cause mortality (RR, 0.93; 95% CI, 0.78-1.11) with PCI. However, for freedom from angina, there was a significant improved outcome with PCI, as compared with OMT (RR, 1.20; 95% CI, 1.06-1.37), evident at all of the follow-up time points. Conclusions: In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.

Original languageEnglish (US)
Pages (from-to)476-490
Number of pages15
JournalCirculation: Cardiovascular Interventions
Volume5
Issue number4
DOIs
StatePublished - Aug 2012

Fingerprint

Percutaneous Coronary Intervention
Meta-Analysis
Coronary Artery Disease
Randomized Controlled Trials
Odds Ratio
Mortality
Myocardial Infarction
Therapeutics
Stents
Myocardial Revascularization
PubMed
Databases
Technology

Keywords

  • Angina
  • Coronary artery disease
  • Optimal medical therapy
  • Percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease : A systematic review and meta-analysis of randomized clinical trials. / Pursnani, Seema; Korley, Frederick; Gopaul, Ravindra; Kanade, Pushkar; Chandra, Newry; Shaw, Richard E.; Bangalore, Sripal.

In: Circulation: Cardiovascular Interventions, Vol. 5, No. 4, 08.2012, p. 476-490.

Research output: Contribution to journalArticle

Pursnani, Seema ; Korley, Frederick ; Gopaul, Ravindra ; Kanade, Pushkar ; Chandra, Newry ; Shaw, Richard E. ; Bangalore, Sripal. / Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease : A systematic review and meta-analysis of randomized clinical trials. In: Circulation: Cardiovascular Interventions. 2012 ; Vol. 5, No. 4. pp. 476-490.
@article{d5df6424bcf74b5f8eab75f92f553fad,
title = "Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials",
abstract = "Background: The role of percutaneous coronary intervention (PCI) in the management of stable coronary artery disease remains controversial. Given advancements in medical therapies and stent technology over the last decade, we sought to evaluate whether PCI, when added to medical therapy, improves outcomes when compared with medical therapy alone. Methods and Results: We performed a systematic review and meta-analysis, searching PubMed, EMBASE, and CENTRAL databases, until January 2012, for randomized clinical trials comparing revascularization with PCI to optimal medical therapy (OMT) in patients with stable coronary artery disease. The primary outcome was all-cause mortality, and secondary outcomes included cardiovascular death, nonfatal myocardial infarction, subsequent revascularization, and freedom from angina. Primary analyses were based on longest available follow-up with secondary analyses stratified by trial duration, with short-term (≤1 year), intermediate (1-5 years), and long-term (≥5 years) time points. We identified 12 randomized clinical trials enrolling 7182 participants who fulfilled our inclusion criteria. For the primary analyses, when compared with OMT, PCI was associated with no significant improvement in mortality (risk ratio [RR], 0.85; 95{\%} CI, 0.71-1.01), cardiac death (RR, 0.71; 95{\%} CI, 0.47-1.06), nonfatal myocardial infarction (RR, 0.93; 95{\%} CI, 0.70-1.24), or repeat revascularization (RR, 0.93; 95{\%} CI, 0.76-1.14), with consistent results over all follow-up time points. Sensitivity analysis restricted to studies in which there was >50{\%} stent use showed attenuation in the effect size for all-cause mortality (RR, 0.93; 95{\%} CI, 0.78-1.11) with PCI. However, for freedom from angina, there was a significant improved outcome with PCI, as compared with OMT (RR, 1.20; 95{\%} CI, 1.06-1.37), evident at all of the follow-up time points. Conclusions: In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.",
keywords = "Angina, Coronary artery disease, Optimal medical therapy, Percutaneous coronary intervention",
author = "Seema Pursnani and Frederick Korley and Ravindra Gopaul and Pushkar Kanade and Newry Chandra and Shaw, {Richard E.} and Sripal Bangalore",
year = "2012",
month = "8",
doi = "10.1161/CIRCINTERVENTIONS.112.970954",
language = "English (US)",
volume = "5",
pages = "476--490",
journal = "Circulation: Cardiovascular Interventions",
issn = "1941-7640",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease

T2 - A systematic review and meta-analysis of randomized clinical trials

AU - Pursnani, Seema

AU - Korley, Frederick

AU - Gopaul, Ravindra

AU - Kanade, Pushkar

AU - Chandra, Newry

AU - Shaw, Richard E.

AU - Bangalore, Sripal

PY - 2012/8

Y1 - 2012/8

N2 - Background: The role of percutaneous coronary intervention (PCI) in the management of stable coronary artery disease remains controversial. Given advancements in medical therapies and stent technology over the last decade, we sought to evaluate whether PCI, when added to medical therapy, improves outcomes when compared with medical therapy alone. Methods and Results: We performed a systematic review and meta-analysis, searching PubMed, EMBASE, and CENTRAL databases, until January 2012, for randomized clinical trials comparing revascularization with PCI to optimal medical therapy (OMT) in patients with stable coronary artery disease. The primary outcome was all-cause mortality, and secondary outcomes included cardiovascular death, nonfatal myocardial infarction, subsequent revascularization, and freedom from angina. Primary analyses were based on longest available follow-up with secondary analyses stratified by trial duration, with short-term (≤1 year), intermediate (1-5 years), and long-term (≥5 years) time points. We identified 12 randomized clinical trials enrolling 7182 participants who fulfilled our inclusion criteria. For the primary analyses, when compared with OMT, PCI was associated with no significant improvement in mortality (risk ratio [RR], 0.85; 95% CI, 0.71-1.01), cardiac death (RR, 0.71; 95% CI, 0.47-1.06), nonfatal myocardial infarction (RR, 0.93; 95% CI, 0.70-1.24), or repeat revascularization (RR, 0.93; 95% CI, 0.76-1.14), with consistent results over all follow-up time points. Sensitivity analysis restricted to studies in which there was >50% stent use showed attenuation in the effect size for all-cause mortality (RR, 0.93; 95% CI, 0.78-1.11) with PCI. However, for freedom from angina, there was a significant improved outcome with PCI, as compared with OMT (RR, 1.20; 95% CI, 1.06-1.37), evident at all of the follow-up time points. Conclusions: In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.

AB - Background: The role of percutaneous coronary intervention (PCI) in the management of stable coronary artery disease remains controversial. Given advancements in medical therapies and stent technology over the last decade, we sought to evaluate whether PCI, when added to medical therapy, improves outcomes when compared with medical therapy alone. Methods and Results: We performed a systematic review and meta-analysis, searching PubMed, EMBASE, and CENTRAL databases, until January 2012, for randomized clinical trials comparing revascularization with PCI to optimal medical therapy (OMT) in patients with stable coronary artery disease. The primary outcome was all-cause mortality, and secondary outcomes included cardiovascular death, nonfatal myocardial infarction, subsequent revascularization, and freedom from angina. Primary analyses were based on longest available follow-up with secondary analyses stratified by trial duration, with short-term (≤1 year), intermediate (1-5 years), and long-term (≥5 years) time points. We identified 12 randomized clinical trials enrolling 7182 participants who fulfilled our inclusion criteria. For the primary analyses, when compared with OMT, PCI was associated with no significant improvement in mortality (risk ratio [RR], 0.85; 95% CI, 0.71-1.01), cardiac death (RR, 0.71; 95% CI, 0.47-1.06), nonfatal myocardial infarction (RR, 0.93; 95% CI, 0.70-1.24), or repeat revascularization (RR, 0.93; 95% CI, 0.76-1.14), with consistent results over all follow-up time points. Sensitivity analysis restricted to studies in which there was >50% stent use showed attenuation in the effect size for all-cause mortality (RR, 0.93; 95% CI, 0.78-1.11) with PCI. However, for freedom from angina, there was a significant improved outcome with PCI, as compared with OMT (RR, 1.20; 95% CI, 1.06-1.37), evident at all of the follow-up time points. Conclusions: In this most rigorous and comprehensive analysis in patients with stable coronary artery disease, PCI, as compared with OMT, did not reduce the risk of mortality, cardiovascular death, nonfatal myocardial infarction, or revascularization. PCI, however, provided a greater angina relief compared with OMT alone, larger studies with sufficient power are required to prove this conclusively.

KW - Angina

KW - Coronary artery disease

KW - Optimal medical therapy

KW - Percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=84868620623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868620623&partnerID=8YFLogxK

U2 - 10.1161/CIRCINTERVENTIONS.112.970954

DO - 10.1161/CIRCINTERVENTIONS.112.970954

M3 - Article

C2 - 22872053

AN - SCOPUS:84868620623

VL - 5

SP - 476

EP - 490

JO - Circulation: Cardiovascular Interventions

JF - Circulation: Cardiovascular Interventions

SN - 1941-7640

IS - 4

ER -